Literature DB >> 11711266

Pharmacokinetics of cefcapene pivoxil and AS-924 in gastrectomized patients.

M Fujimoto1.   

Abstract

To investigate the effects of gastrectomy on the absorption of drugs, the blood concentrations of the active moieties, cefcapene (CCAP) and ceftizoxime (CTIZ), were determined in 36 gastrectomized patients after oral administration of cefcapene pivoxil (CCAP-PI) and AS-924, prodrug type cephem antibiotics with different solubility-profiles. In patients with gastrectomy, the C(max) and AUC for CCAP-PI whose solubility depended on the acidity of gastric juice, were lower than in the controls; whereas those for AS-924 were comparable with values in the control group. The T(max) was affected by the extent of gastrectomy; the T(max) value was the lowest in patients who had undergone total gastrectomy Roux-Y, followed by Billroth II and Billroth I procedure of subtotal gastrectomy. These results indicate the need to select drugs and to instruct gastrectomized patients regarding dosage and administration, taking the pharmacokinetics of drugs into consideration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711266     DOI: 10.1016/s0924-8579(01)00446-0

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  3 in total

1.  Absorption of ester prodrugs in Caco-2 and rat intestine models.

Authors:  Xin He; Mitsuru Sugawara; Yoh Takekuma; Katsumi Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  Determination of cefcapene acid by LC-MS and their application to a pharmacokinetic study in healthy Chinese volunteers.

Authors:  Hong-Fei Duan; Li Ding; Xiao-Bing Li; Lin-Lin Hu; Ai-Dong Wen; Ye Leng; Zhen Liu
Journal:  J Pharm Anal       Date:  2012-10-07

3.  Stability-Indicating HPLC Method for the Determination of Cefcapene Pivoxil.

Authors:  Przemysław Zalewski; Judyta Cielecka-Piontek; Piotr Garbacki; Anna Jelińska; Marta Karaźniewicz-Łada
Journal:  Chromatographia       Date:  2012-09-18       Impact factor: 2.044

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.